[1] Inker LA, Coresh J, Levey AS, Tonelli M, Muntner P. Estimated GFR, albuminuria, and complications of chronic kidney disease. J Am Soc Nephrol. 2011. 22(12): 2322-31.
[2] Stevens PE, Levin A, Kidney Disease: Improving Global Outcomes Chronic Kidney Disease Guideline Development Work Group Members. Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline. Ann Intern Med. 2013. 158(11): 825-30.
[3] Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004. 351(13): 1296-305.
[4] Chronic Kidney Disease Prognosis Consortium, Matsushita K, van der Velde M, et al. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet. 2010. 375(9731): 2073-81.
[5] Gansevoort RT, Matsushita K, van der Velde M, et al. Lower estimated GFR and higher albuminuria are associated with adverse kidney outcomes. A collaborative meta-analysis of general and high-risk population cohorts. Kidney Int. 2011. 80(1): 93-104.
[6] Mahmoodi BK, Matsushita K, Woodward M, et al. Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without hypertension: a meta-analysis. Lancet. 2012. 380(9854): 1649-61.
[7] Hsu CY, Ordoñez JD, Chertow GM, Fan D, McCulloch CE, Go AS. The risk of acute renal failure in patients with chronic kidney disease. Kidney Int. 2008. 74(1): 101-7.
[8] Astor BC, Matsushita K, Gansevoort RT, et al. Lower estimated glomerular filtration rate and higher albuminuria are associated with mortality and end-stage renal disease. A collaborative meta-analysis of kidney disease population cohorts. Kidney Int. 2011. 79(12): 1331-40.
[9] Hill NR, Fatoba ST, Oke JL, et al. Global Prevalence of Chronic Kidney Disease - A Systematic Review and Meta-Analysis. PLoS One. 2016. 11(7): e0158765.
[10] Li PK, Kwan BC, Leung CB, et al. Prevalence of silent kidney disease in Hong Kong: the screening for Hong Kong Asymptomatic Renal Population and Evaluation (SHARE) program. Kidney Int Suppl. 2005. (94): S36-40.
[11] System USRD. US Renal Data System 2019 Annual Data Report: Epidemiology of Kidney Disease in the United States. https://www.usrds.org/2019/download/USRDS_2019_ES_final.pdf. : 31-2.
[12] Li PK, Chow KM, Matsuo S, et al. Asian chronic kidney disease best practice recommendations: positional statements for early detection of chronic kidney disease from Asian Forum for Chronic Kidney Disease Initiatives (AFCKDI). Nephrology (Carlton). 2011. 16(7): 633-41.
[13] Brück K, Stel VS, Gambaro G, et al. CKD Prevalence Varies across the European General Population. J Am Soc Nephrol. 2016. 27(7): 2135-47.
[14] [Accessed 30 Oct 2019]System USRD. US Renal Data System 2018 Annual Data Report. Chapter 1: CKD in the General Population. https://www.usrds.org/2018/download/v1_c01_GenPop_18_usrds.pdf .
[15] Tsai MH, Hsu CY, Lin MY, et al. Incidence, Prevalence, and Duration of Chronic Kidney Disease in Taiwan: Results from a Community-Based Screening Program of 106,094 Individuals. Nephron. 2018. 140(3): 175-184.
[16] Wan E, Yu E, Chin WY, Fong D, Choi E, Lam C. Association of Blood Pressure and Risk of Cardiovascular and Chronic Kidney Disease in Hong Kong Hypertensive Patients. Hypertension. 2019. 74(2): 331-340.
[17] Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009. 150(9): 604-12.
[18] Stevens LA, Levey AS. Measured GFR as a confirmatory test for estimated GFR. J Am Soc Nephrol. 2009. 20(11): 2305-13.
[19] Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976. 16(1): 31-41.
[20] Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999. 130(6): 461-70.
[21] Myers GL, Miller WG, Coresh J, et al. Recommendations for improving serum creatinine measurement: a report from the Laboratory Working Group of the National Kidney Disease Education Program. Clin Chem. 2006. 52(1): 5-18.
[22] Zhang QL, Rothenbacher D. Prevalence of chronic kidney disease in population-based studies: systematic review. BMC Public Health. 2008. 8: 117.
[23] Rahman M, Brown CD, Coresh J, et al. The prevalence of reduced glomerular filtration rate in older hypertensive patients and its association with cardiovascular disease: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. Arch Intern Med. 2004. 164(9): 969-76.
[24] Ravera M, Noberasco G, Weiss U, et al. CKD awareness and blood pressure control in the primary care hypertensive population. Am J Kidney Dis. 2011. 57(1): 71-7.
[25] Leoncini G, Viazzi F, Rosei EA, et al. Chronic kidney disease in hypertension under specialist care: the I-DEMAND study. J Hypertens. 2010. 28(1): 156-62.
[26] Glassock RJ, Winearls C. Ageing and the glomerular filtration rate: truths and consequences. Trans Am Clin Climatol Assoc. 2009. 120: 419-28.
[27] Sobamowo H, Prabhakar SS. The Kidney in Aging: Physiological Changes and Pathological Implications. Prog Mol Biol Transl Sci. 2017. 146: 303-340.
[28] Kottgen A, Russell SD, Loehr LR, et al. Reduced kidney function as a risk factor for incident heart failure: the atherosclerosis risk in communities (ARIC) study. J Am Soc Nephrol. 2007. 18(4): 1307-15.
[29] Bagshaw SM, Cruz DN, Aspromonte N, et al. Epidemiology of cardio-renal syndromes: workgroup statements from the 7th ADQI Consensus Conference. Nephrol Dial Transplant. 2010. 25(5): 1406-16.
[30] McCullough PA, Philbin EF, Spertus JA, et al. Confirmation of a heart failure epidemic: findings from the Resource Utilization Among Congestive Heart Failure (REACH) study. J Am Coll Cardiol. 2002. 39(1): 60-9.
[31] Alicic RZ, Rooney MT, Tuttle KR. Diabetic Kidney Disease: Challenges, Progress, and Possibilities. Clin J Am Soc Nephrol. 2017. 12(12): 2032-2045.
[32] Fessel WJ. Renal outcomes of gout and hyperuricemia. Am J Med. 1979. 67(1): 74-82.
[33] Stack AG, Johnson ME, Blak B, et al. Gout and the risk of advanced chronic kidney disease in the UK health system: a national cohort study. BMJ Open. 2019. 9(8): e031550.
[34] Roughley M, Sultan AA, Clarson L, et al. Risk of chronic kidney disease in patients with gout and the impact of urate lowering therapy: a population-based cohort study. Arthritis Res Ther. 2018. 20(1): 243.
[35] Wang W, Bhole VM, Krishnan E. Chronic kidney disease as a risk factor for incident gout among men and women: retrospective cohort study using data from the Framingham Heart Study. BMJ Open. 2015. 5(4): e006843.
[36] Kasiske BL. Hyperlipidemia in patients with chronic renal disease. Am J Kidney Dis. 1998. 32(5 Suppl 3): S142-56.
[37] Zoppini G, Targher G, Chonchol M, Perrone F, Lippi G, Muggeo M. Higher HDL cholesterol levels are associated with a lower incidence of chronic kidney disease in patients with type 2 diabetes. Nutr Metab Cardiovasc Dis. 2009. 19(8): 580-6.
[38] Kawachi K, Kataoka H, Manabe S, Mochizuki T, Nitta K. Low HDL cholesterol as a predictor of chronic kidney disease progression: a cross-classification approach and matched cohort analysis. Heart Vessels. 2019. 34(9): 1440-1455.
[39] Kronenberg F. HDL in CKD-The Devil Is in the Detail. J Am Soc Nephrol. 2018. 29(5): 1356-1371.